Click here for additional news beyond press releases.


Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000


December 20, 2010
Celera Announces Appointment of Alfred Merriweather as Chief Financial Officer
November 3, 2010
Celera Corporation Reports Third Quarter 2010 Results
additional: Celera Corporation Teleconference November 2010 Management Remarks for Third Quarter 2010 Earnings Call
October 20, 2010
Celera Corporation Third Quarter 2010 Results and Conference Call Scheduled for November 3, 2010
October 7, 2010
Celera Says Case-control Publication on KIF6 Does Not Refute Prior Research on KIF6's Association with Coronary Heart Disease and Statin Benefit
October 4, 2010
Celera Announces Resignation of Chief Financial Officer
September 21, 2010
Celera Announces Issuance of United States Patent Relating to KIF6 Gene Variant as a Predictor of Increased Risk of Myocardial Infarction and Reduction of Such Risk Following Statin Therapy
September 20, 2010
Celera Signs Agreement with Abbott for Distribution of CE-marked KIF6 Test to Identify Patients at Risk of Coronary Heart Disease
September 14, 2010
Celera to Webcast its Presentation at the UBS Global Life Sciences Conference
August 25, 2010
Celera Announces Issuance of United States Patent Relating to LPA Gene Variant Associated with Increased Risk for Myocardial Infarction
August 18, 2010
Celera Publishes Review Article on the KIF6 Gene Variant as a Predictor of Risk of Coronary Heart Disease (CHD) and Reduction in Coronary Events from Statin Therapy
August 3, 2010
Celera Corporation Reports Second Quarter 2010 Results
additional: Celera Corporation Teleconference August 2010 Management Remarks for Second Quarter 2010 Earnings Call
July 23, 2010
Celera Corporation Second Quarter 2010 Results and Conference Call Scheduled for August 3, 2010
June 15, 2010
Celera Says Purported Class Action Lawsuit is Without Merit
June 8, 2010
Celera Publishes Data Validating an Increased Risk of Coronary Heart Disease in Carriers of Two LPA Gene Variants
June 7, 2010
Celera Announces CE Mark for KIF6 Test
May 7, 2010
Celera to Webcast Presentation at the Ninth Annual JMP Securities Research Conference on May 12, 2010
April 28, 2010
Celera Corporation Reports First Quarter 2010 Results
additional: Celera Corporation Teleconference April 2010 Management Remarks for First Quarter 2010 Earnings Call
April 22, 2010
Celera Corporation Announces Settlement Agreement with Health Diagnostic Laboratory, Inc., Blue Wave Healthcare Consultants, Inc., and Former BHL Employees
April 19, 2010
Celera Corporation First Quarter 2010 Results and Conference Call Scheduled for April 28, 2010
April 12, 2010
Celera Presents Data Describing the Biology of KIF6, a Genetic Marker for the Management of CHD
March 24, 2010
Celera Publishes Data Extending the Association Between the KIF6 Gene Variant and Differential Reduction of Coronary Events from Statin Therapy to the Elderly with Prior Vascular Disease
March 3, 2010
Berkeley HeartLab Receives College of American Pathologists Accreditation
March 3, 2010
Celera Corporation Reports Fourth Quarter and Full Year 2009 Results
additional: Celera Corporation Teleconference March 2010 Management Remarks for Fourth Quarter and Full Year 2009 Earnings Call
March 2, 2010
Celera to Webcast Presentation at the Cowen Healthcare Conference on March 9, 2010
February 19, 2010
Celera Corporation Provides Information on Litigation Against Health Diagnostic Laboratory, Inc.
February 17, 2010
Celera Corporation Fourth Quarter and 2009 Results and Conference Call Scheduled for March 3, 2010
February 11, 2010
QIAGEN and Celera Establish Distribution Agreement for Respiratory Pathogen Panel
January 12, 2010
Celera Grants A License to The University of California, San Francisco for the Development of KIF6 Testing
January 5, 2010
Celera to Webcast Presentation at JPMorgan Healthcare Conference